JP2021516674A5 - - Google Patents

Info

Publication number
JP2021516674A5
JP2021516674A5 JP2020544501A JP2020544501A JP2021516674A5 JP 2021516674 A5 JP2021516674 A5 JP 2021516674A5 JP 2020544501 A JP2020544501 A JP 2020544501A JP 2020544501 A JP2020544501 A JP 2020544501A JP 2021516674 A5 JP2021516674 A5 JP 2021516674A5
Authority
JP
Japan
Prior art keywords
unsubstituted
group
substituted
cancer
alkyl
Prior art date
Application number
JP2020544501A
Other languages
English (en)
Japanese (ja)
Other versions
JP7369132B2 (ja
JPWO2019165192A5 (https=
JP2021516674A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/019129 external-priority patent/WO2019165192A1/en
Publication of JP2021516674A publication Critical patent/JP2021516674A/ja
Publication of JP2021516674A5 publication Critical patent/JP2021516674A5/ja
Publication of JPWO2019165192A5 publication Critical patent/JPWO2019165192A5/ja
Application granted granted Critical
Publication of JP7369132B2 publication Critical patent/JP7369132B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544501A 2018-02-23 2019-02-22 5-ヘテロアリール置換イミダゾール-3-カルボキサミドならびにその調製および使用の方法 Active JP7369132B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862634656P 2018-02-23 2018-02-23
US62/634,656 2018-02-23
PCT/US2019/019129 WO2019165192A1 (en) 2018-02-23 2019-02-22 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

Publications (4)

Publication Number Publication Date
JP2021516674A JP2021516674A (ja) 2021-07-08
JP2021516674A5 true JP2021516674A5 (https=) 2022-02-24
JPWO2019165192A5 JPWO2019165192A5 (https=) 2022-02-24
JP7369132B2 JP7369132B2 (ja) 2023-10-25

Family

ID=65812386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544501A Active JP7369132B2 (ja) 2018-02-23 2019-02-22 5-ヘテロアリール置換イミダゾール-3-カルボキサミドならびにその調製および使用の方法

Country Status (18)

Country Link
US (2) US10934297B2 (https=)
EP (1) EP3755696B1 (https=)
JP (1) JP7369132B2 (https=)
KR (1) KR102861944B1 (https=)
CN (1) CN112020501A (https=)
AU (1) AU2019224075A1 (https=)
BR (1) BR112020017087A2 (https=)
CA (1) CA3091913A1 (https=)
CL (1) CL2020002177A1 (https=)
EA (1) EA202092002A1 (https=)
ES (1) ES2945558T3 (https=)
IL (1) IL276814A (https=)
MA (1) MA51908A (https=)
MX (1) MX2020008852A (https=)
PE (1) PE20211447A1 (https=)
PH (1) PH12020551300A1 (https=)
SG (1) SG11202008029UA (https=)
WO (1) WO2019165192A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019224075A1 (en) 2018-02-23 2020-09-10 Samumed, Llc 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
PT3790873T (pt) * 2018-05-07 2022-05-11 Acraf Compostos de 1h-indazole-3-carboxamida como inibidores da glicogénio sintase cinase 3 beta
JP7444458B2 (ja) * 2018-09-21 2024-03-06 学校法人福岡大学 プリオン病治療薬
JP2023506257A (ja) * 2019-12-16 2023-02-15 コリア リサーチ インスティチュート オブ ケミカル テクノロジー 新規なインダゾール誘導体及びその用途
WO2021120890A1 (en) 2019-12-20 2021-06-24 Novartis Ag Pyrazolyl derivatives useful as anti-cancer agents
AU2024301960A1 (en) * 2023-06-14 2026-01-22 Prothena Biosciences Limited Bicyclic heteroaromatic compounds for treating neurological disorders

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164559A (en) 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
US6440102B1 (en) 1998-07-23 2002-08-27 Durect Corporation Fluid transfer and diagnostic system for treating the inner ear
DE19853299C2 (de) 1998-11-19 2003-04-03 Thomas Lenarz Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
US6120484A (en) 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US6648873B2 (en) 2001-09-21 2003-11-18 Durect Corp. Aural catheter system including anchor balloon and balloon inflation device
GB0218625D0 (en) * 2002-08-10 2002-09-18 Astex Technology Ltd Pharmaceutical compounds
MXPA05003317A (es) 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
FR2845382A1 (fr) 2002-10-02 2004-04-09 Sanofi Synthelabo Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
FR2867778B1 (fr) * 2004-03-16 2006-06-09 Sanofi Synthelabo Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
NZ550534A (en) 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
UA93348C2 (ru) * 2004-03-25 2011-02-10 Меморі Фармас'Ютікалз Корпорейшн Индазолы, бензотиазолы, бензоизотиазолы, их получение и применение
WO2011050245A1 (en) * 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN103889976A (zh) * 2011-08-12 2014-06-25 弗·哈夫曼-拉罗切有限公司 吲唑化合物、组合物及使用方法
EP3473099A1 (en) * 2011-09-14 2019-04-24 Samumed, LLC Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
CA2860250C (en) * 2012-02-21 2020-11-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
PH12017500997A1 (en) 2012-04-04 2018-02-19 Samumed Llc Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
MX2016012208A (es) * 2014-03-20 2017-01-26 Samumed Llc Indazol-3-carboxamidas 5-substituidas y preparacion y uso de las mismas.
WO2016040182A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
BR112018009252A2 (pt) 2015-11-06 2018-11-06 Samumed Llc tratamento da osteoartrite
LT3464285T (lt) 2016-06-01 2022-12-27 Biosplice Therapeutics, Inc. N-(5-(3-(7-(3-fluorfenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)- 3-metilbutanamido gamybos būdas
CN110709082A (zh) * 2016-10-21 2020-01-17 萨穆梅德有限公司 吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途
AU2019224075A1 (en) 2018-02-23 2020-09-10 Samumed, Llc 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

Similar Documents

Publication Publication Date Title
JP2021516674A5 (https=)
JP2019514938A5 (https=)
JP2016504387A5 (https=)
JP2014526510A5 (https=)
JP2017508763A5 (https=)
RU2016141088A (ru) 5-замещённые индазол-3-карбоксамиды и их получение и применение
JP2015512443A5 (https=)
CN106188045B (zh) 作为wnt信号传导抑制剂的化合物、组合物及其应用
ES2445526T3 (es) Acetamidas con sustitución N-(hetero)aril, 2-(hetero)arilo para utilizar como moduladores de señalización de Wnt
CN111032647B (zh) 溶血磷脂酸受体1(lpar1)抑制剂化合物
CN104955456B (zh) 作为分拣蛋白抑制剂的n-取代的-5-取代的邻氨甲酰苯甲酸
RU2014148773A (ru) 1н-пиразоло[3,4-b]пиридины и их терапевтические применения
TWI691475B (zh) Urat1抑制劑
JP2010522770A5 (https=)
JP2019524702A (ja) テトラヒドロナフチルリジンペンタンアミドインテグリンアンタゴニスト
JP6853819B2 (ja) Wntシグナル伝達経路阻害剤およびその治療用途
JPWO2008136378A1 (ja) 新規なスルホンアミド誘導体またはその塩
JP2016508152A (ja) Cracチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類i
JPWO2019165192A5 (https=)
CN105377837B (zh) 用作s100‑抑制剂的n‑(杂芳基)磺酰胺衍生物
RU2018141395A (ru) Изохинолин-3-иловые карбоксамиды и их получение и применение
JP7025542B2 (ja) Tgf-ベータ阻害剤としてのオキサジアゾール及びチアジアゾール
TH1801006577A (th) ไอโซควิโนลิน-3-อิล คาร์บอกซาไมด์ และการเตรียม และการใช้สิ่งดังกล่าว
WO2019005297A1 (en) BACE1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BR112020002217B1 (pt) Compostos inibidores do receptor de ácido lisfosfatídico 1 (lpar1)